Han-Ying Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Han-Ying Lin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Bin Liu
Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China
1 shared publication - Fan Cao
Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China
1 shared publication - Jing Chen
Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China
1 shared publication - Xinhua Ma
Faculty of Pharmacy, Fujian Medical University, Fuzhou 350122, China
1 shared publication - Yong-Hong Zhang
Key Laboratory of Natural Drug Pharmacology in Fujian Province, School of Pharmacy, Fujian Medical University, 88 Jiao Tong Road, Fuzhou, 350004, P. R. China
1 shared publication - Zhen-Wei Chen
Provincial Key Laboratory of Natural Drug Pharmacology, Department of Pharmacy, Fujian Medical University, Fuzhou 350122, China
1 shared publication
Latest Publications
- Open Access
- 31 October 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1338
Chemical Constituents from the Fruit of Melia azedarach and Their Anti-Inflammatory Activity
Phytochemical investigations of Melia azedarach fruits have led to the isolation of a novel tirucallane triterpenoid (1), four new limonoids (2–5), and four known limonoids (6–9). Their structures were clarified by comprehensive spectroscopic and spectrometric analyses. The anti-inflammatory activities of isolated compounds were assessed in vitro. Compound 2 exhibited the most potent anti-inflammatory effect, with an IC50 value of 22.04 μM. Additionally, compound 2 attenuated LPS-induced reactive oxygen species (ROS) production and reduced the levels of inflammatory mediators IL-6 and TNF-α. A mechanistic study revealed that limonoid 2 suppresses the expression of iNOS and JAK2 and is implicated in the modulation of the NF-κB signaling cascade, which reveals its anti-inflammatory actions.
- 31 October 2024
- Published by MDPI AG in Antioxidants
- Vol. 13 (11) , 1338
Open AccessChemical Constituents from the Fruit of Melia azedarach and Their Anti-Inflammatory Activity
Phytochemical investigations of Melia azedarach fruits have led to the isolation of a novel tirucallane triterpenoid (1), four new limonoids (2–5), and four known limonoids (6–9). Their structures were clarified by comprehensive spectroscopic and spectrometric analyses. The anti-inflammatory activities of isolated compounds were assessed in vitro. Compound 2 exhibited the most potent anti-inflammatory effect, with an IC50 value of 22.04 μM. Additionally, compound 2 attenuated LPS-induced reactive oxygen species (ROS) production and reduced the levels of inflammatory mediators IL-6 and TNF-α. A mechanistic study revealed that limonoid 2 suppresses the expression of iNOS and JAK2 and is implicated in the modulation of the NF-κB signaling cascade, which reveals its anti-inflammatory actions.